Advagene Biopharma6709 
$0.761.04%24h
1.04%24h
Global rank26417
Market cap$40.37M
Change 7d0.00%
YTD Performance-7.98%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Market capitalization of Advagene Biopharma (6709)
As of November 2024, Advagene Biopharma has a market cap of $40.37M. This makes Advagene Biopharma the world's 26417th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Advagene Biopharma from 2018 to 2024
-
Value:-
Market cap history of Advagene Biopharma from 2018 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $39.03M | -10.69% |
| 2023 | $43.70M | -12.81% |
| 2022 | $50.12M | -37.46% |
| 2021 | $80.15M | 45.39% |
| 2020 | $55.13M | 65.25% |
| 2019 | $33.36M | -23.08% |
| 2018 | $43.37M | - |
6709 Market Cap Today is $40.37M 1.04% - 9 Nov 2024
View largest stocks by market cap 
